Core Insights - Ocumetics Technology Corp. has successfully completed the one-week postoperative examination of the first patients implanted with the Ocumetics Accommodating Intraocular Lens, with all patients recovering well and no complications observed [1][3] - The company is now recruiting additional individuals to complete the first group of patients for the Ocumetics Lens [2] - The Ocumetics Lens aims to redefine vision correction by allowing the eye's natural muscular activity to focus on both distant and near objects without the need for glasses or contact lenses after cataract surgery [3][5] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions to enhance patients' quality of life [4] - The company is dedicated to transforming the field of ophthalmology through innovative research and development of state-of-the-art intraocular lenses and other vision-enhancing technologies [4] Product Development - The Ocumetics Lens is designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses by providing clear vision at all distances [5] - The company is currently in the preclinical study phase for this groundbreaking technology in the ophthalmic industry [5]

"This is a moment our entire team has been working toward for years," said Dean Burns, CEO of Ocumetics. "Every milestone we've achieved in recent weeks reflects the dedication, expertise, and sheer determination of our people and partners. We're now just a few days away from transforming the future of vision correction with the first implantation of our groundbreaking accommodating intraocular lens. I couldn't be prouder of what our team has accomplished." Calgary, Alberta – TheNewswire - August 12, 2025 - ...

Calgary, Alberta – TheNewswire - July 30, 2025 - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce that the ethics committee of the clinical site in Mexico City overseeing the first in-human study of the Ocumetics accommodating intraocular lens (the "Ocumetics Lens") has verbally approved the protocol for the study. Formal written approval is expected by August 5, 2025. Dean Burns, CEO of Ocume ...

Core Insights - Ocumetics Technology Corp. has achieved a significant breakthrough in the development of next-generation intraocular lens technology, demonstrating accommodative power change in laboratory testing [1][2] - The company plans to prepare for first-in-human studies scheduled for summer 2025, following successful laboratory results [2][3] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions aimed at enhancing patients' quality of life [4] - The company is dedicated to transforming the field of ophthalmology through innovative research and development of state-of-the-art intraocular lenses and other vision-enhancing technologies [4] Technological Development - The intraocular lens developed by Ocumetics is designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses [5] - This lens allows the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the assistance of glasses or contact lenses [5] Research and Development - The testing utilized Ocumetics' Lens Analyzer (IOLA) bench testing platform to simulate ciliary body pressures, confirming the lens's ability to respond dynamically [2][3] - The company continues to collaborate with leading ophthalmic researchers, engineers, and clinical advisors to advance its rigorous R&D roadmap [3]